GC
IBRX icon

Gould Capital’s ImmunityBio IBRX Stock Holding History

Gould Capital’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$897 Hold
117
– – ﹤0.01% 193
2025
Q4 		$232 Hold
117
– – ﹤0.01% 199
2025
Q3 		$288 Hold
117
– – ﹤0.01% 209
2025
Q2 		$309 Hold
117
– – ﹤0.01% 209
2025
Q1 		$352 Hold
117
– – ﹤0.01% 207
2024
Q4 		$300 Hold
117
– – ﹤0.01% 210
2024
Q3 		$435 Buy
+117
New +$541 ﹤0.01% 208

Other funds holding IBRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return